Kim Linton, MD, PhD^1*, Wojciech Jurczak, MD, PhD², Pieternella Lugtenburg, MD, PhD³, Emmanuel Gyan, MD, PhD^4*, Anna Maria Sureda Balari, MD, PhD⁵, Jacob Haaber Christensen, MD, PhD^6*, Brian Hess, MD⁷, Hervé Tilly, MD, PhD⁸, Raul Cordoba, MD, PhD⁹, David Lewis, MBChB, PHD^10*, Craig Okada, MD¹¹, Martin Hutchings, MD, PhD^12*, Michael Roost Clausen, MD, PhD^13*, Umberto Vitolo, MD¹⁴, Tara Cochrane, MBBS, FRCPA, FRACP¹⁵, Sirpa Leppa, MD, PhD^16*, Martine E.D. Chamuleau, MD, PhD^17*, Rebekah Conlon, BN^18*, Elena Favaro, MD, PhD^19*, Diana Gernhardt^20*, Isil Altintas, PhD^21*, Yan Liu, PhD^20* and Catherine Thieblemont, MD^22*

¹The Christie NHS Foundation Trust and Manchester Cancer Research Centre, Manchester, United Kingdom
²Dpt of Clinical Oncology, MSC National Research Institute of Oncology, Kraków, Poland
³Department of Hematology, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, Rotterdam, Netherlands
⁴Centre Hospitalier Universitaire de Tours, Tours, France
⁵Institut Català d’Oncologia, Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, L’Hospitalet de Llobregat, Barcelona, Spain
⁶Department of Hematology, Odense University Hospital, Odense C., DNK
⁷Medical University of South Carolina, Charleston, SC
⁸Centre Henri-Becquerel and University of Rouen, Rouen, France
⁹Fundacion Jimenez Diaz University Hospital, Madrid, Spain
¹⁰University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
¹¹Knight Cancer Institute, Oregon Health & Science University, Portland, OR
¹²Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
¹³Department of Hematology, Vejle Hospital, Vejle, DNK
¹⁴Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy
¹⁵Department of Haematology, Gold Coast University Hospital, Southport, Australia
¹⁶University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
¹⁷On behalf of the Lunenburg Lymphoma Phase I/II Consortium-HOVON/LLPC, Amsterdam UMC, VU University Medical Center, Amsterdam, NLD
¹⁸AbbVie, North Chicago, IL
¹⁹Genmab, Copenhagen, Denmark
²⁰Genmab, Plainsboro, NJ
²¹Genmab, Utrecht, Netherlands
²²Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, Hemato-oncologie, Université de Paris, Paris, France

Yucai Wang, MD, PhD¹, Melissa C. Larson, MS^2*, Umar Farooq³, Sara Ekberg, PhD^4*, Karin Ekstroem Smedby, MD, PhD^5*, Mikkel Runason Simonsen, MSc^6*, Carsten Utoft Niemann, MD, PhD^7*, Eric J. Zhao, MD, PhD^8*, Alina S. Gerrie, MD, FRCPC, MPH⁸, Jeffrey M. Switchenko, PhD, MS^9*, David A. Bond, MD, BS¹⁰, Veronika Bachanova, MD, PhD¹¹, Stefan K. Barta, MD^12,13, Brian T. Hill, MD¹⁴, Peter Martin, MD¹⁵, Alexey Danilov, MD^16,17, Natalie S. Grover, MD¹⁸, Reem Karmali, MD, MSc¹⁹, Nilanjan Ghosh, MD, PhD²⁰, Timothy S. Fenske, MD^21*, Brad S. Kahl, MD²², Alexandra Albertsson-Lindblad, MD, PhD^23*, Ingrid Cecilia Glimelius, MD, PhD^24*, Ahmed Ludvigsen Al-Mashhadi^25*, Thomas Stauffer Larsen^26*, Kami J. Maddocks, MD²⁷, Brian K. Link, MD^28*, Jonas Paludo, MD²⁹, Grzegorz S. Nowakowski, MD¹, Thomas M. Habermann, MD¹, Matthew J. Maurer, DSc³⁰, Diego Villa, MD³¹, Jonathon B. Cohen, MD, MS⁹, Tarec Christoffer Christoffer El-Galaly, MD, DSc³², Mats Jerkeman, MD, PhD²³ and James R. Cerhan, MD, PhD³⁰

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Division of Epidemiology, Mayo Clinic, Rochester, MN
³Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁴Karolinska Institute, Stockholm, Sweden
⁵Karolinska University Hospital, Stockholm, Sweden
⁶Department of Hematology, Aalborg University Hospital, Aalborg, AL, Denmark
⁷Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
⁸BC Cancer, Vancouver, Canada
⁹Emory University, Atlanta, GA
¹⁰The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
¹¹Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN
¹²Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
¹³The Fox Chase Cancer Center Foundation, Philadelphia, PA
¹⁴Cleveland Clinic, Cleveland, OH
¹⁵Weill Cornell Medicine, New York
¹⁶Department of Hematology and HCT, City of Hope National Medical Center, La Canada Flintridge, CA
¹⁷Knight Cancer Institute, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR
¹⁸The University of North Carolina at Chapel Hill, Chapel Hill, NC
¹⁹Northwestern University, Chicago, IL
²⁰Atrium Health Levine Cancer Institute, Charlotte, NC
²¹Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
²²Washington University School of Medicine in St. Louis, Saint Louis, MO
²³Lund University, Lund, Sweden
²⁴Cancer Precision Medicine, Uppsala University, Uppsala, Sweden
²⁵Department of Hematology, Aalborg University Hospital, Viborg, Denmark
²⁶Department of Hematology, Odense University Hospital, Odense, Denmark
²⁷The James Cancer Center, Ohio State University Hospital, Columbus, OH
²⁸Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
²⁹Mayo Clinic, Rochester, MN
³⁰Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
³¹Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
³²Department of Hematology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark

Carla Casulo, MD¹, Melissa C. Larson, MS^2*, Christopher R. Flowers, MD, MS³, Thomas M. Habermann, MD⁴, Thomas E. Witzig, MD⁵, Yucai Wang, MD, PhD⁴, Grzegorz S. Nowakowski, MD⁴, Andrew L. Feldman, MD⁶, Loretta J. Nastoupil, MD⁷, Dai Chihara, MD, PhD³, Richard Burack, MD, PhD⁸, Jonathan R Day, MD, PharmD⁹, Urshila Durani, MD, MPH⁴, Peter Martin, MD¹⁰, Jonathon B. Cohen, MD, MS¹¹, Jonathan W. Friedberg, MD, MMSc¹, Izidore S. Lossos, MD¹², Brad S. Kahl, MD¹³, Brian K. Link, MD^14*, James R. Cerhan, MD, PhD¹⁵ and Matthew J. Maurer, DSc¹⁶

¹Wilmot Cancer Center, University of Rochester, Rochester, NY
²Department of Quantitative Health Sciences, Mayo Clinic College of Medicine, Rochester, MN
³Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Division of Hematology, Mayo Clinic, Rochester, MN
⁵Mayo Clinic, Rochester, MN
⁶Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester, MN
⁷MD Anderson Cancer Center, Houston, TX
⁸Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY
⁹Department of Internal Medicine, University of Iowa, Iowa City, IA
¹⁰Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
¹¹Winship Cancer Institute, Emory University, Atlanta, GA
¹²Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami School of Medicine, Miami, FL
¹³School of Medicine, Washington University in St. Louis, St Louis, MO
¹⁴University of Iowa, Iowa City, IA
¹⁵Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
¹⁶Department of Health Sciences Research, Mayo Clinic, Rochester, MN

Changju Qu, PhD^1*, Nana Ping, M.D.^2*, Rui Zou, B.S.^2*, Jiajie He, B.S.^2*, Qian Zhu, M.D.^2*, Xiao Zhang, M.D.^2*, Fan Xia, M.D.^3*, Danqing Kong, M.D.^2*, Depei Wu⁴ and Zhengming Jin, B.S.^2*

¹Department of Hematology, Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
²Department of Hematology, Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, the First Affiliated Hospital of Soochow University, Suzhou, China
³Department of Pharmacy, the First Affiliated Hospital of Soochow University, Suzhou, China
⁴The First Affiliated Hospital of Soochow University, Suzhou, China

Chan Y. Cheah, MD¹, Katharine L. Lewis¹, Rory Bennett, MBBS^2*, Amanda Jane Johnston, FRACP, FRCPA, MBBS, BMBS, MD³, Joel Wight, MBBS⁴, Jing Xie^5*, Stella Vlahos^6*, Katrina Celeste^7*, Sally Binks^8* and John F. Seymour, MBBS, PhD, FRACP⁹

¹Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia
²Peter MacCallum Cancer Centre, Department of Haematology, Melbourne, Australia
³Westmead Hospital, Westmead, NSW, AUS
⁴Peter Maccallum Cancer Center, Douglas, Qld, AUS
⁵Peter Maccallum Cancer Centre, Melbourne, AUS
⁶Centre for Biostatistics and Clinical Trials, Melbourne, Australia
⁷Peter MacCallum Cancer Centre, Melbourne, Australia
⁸Sir Charles Gairdner Hospital, Perth, Australia
⁹Peter MacCallum Cancer Center, Royal Melbourne Hospital and University of Melbourne, Melbourne, VIC, Australia

Krish Patel, MD¹, Julie M. Vose, MD, MBA², Sunita D. Nasta, MD, FACP^3*, Jennifer R. Brown, MD, PhD⁴, Kami J. Maddocks, MD⁵, Jennifer A. Woyach, MD^5*, Nirav N. Shah, MD⁶, Bita Fakhri, MD, MPH⁷, Benoit Tessoulin^8*, Shuo Ma, MD, PhD⁹, Deepa Jagadeesh, MD¹⁰, Ewa Lech-Maranda, MD, PhD^11*, Catherine C. Coombs, MD¹², Manish Patel, MD^13*, Joanna M. Rhodes, MD¹⁴, Chaitra S Ujjani, MD¹⁵, Marc Hoffmann, MD¹⁶, Chan Y Cheah, MBBS, FRACP, FRCPA, DMSc¹⁷, Talha Munir, MBBS, MRCP, FRCPath, PhD^18*, David Lewis, MBChB, PHD^19*, Lydia Scarfo, MD²⁰, Toby A. Eyre^21*, Alvaro J. Alencar, MD²², Jonathon B. Cohen, MD, MS²³, Andrew D. Zelenetz, MD, PhD²⁴, Donald E. Tsai, MD, PhD^25*, Mei Li, MS^26*, Faith Bian, PhD^26*, Paolo Abada, MD²⁵ and Pier Luigi Zinzani, MD, PhD²⁷

¹Swedish Cancer Institute, Seattle, WA
²University of Nebraska Medical Center, Omaha, NE
³Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁴Chronic Lymphocytic Leukemia Center, Division of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA
⁵The Ohio State University Comprehensive Cancer Center, Columbus, OH
⁶Medical College of Wisconsin, Milwaukee, WI
⁷Stanford University School of Medicine, Stanford, CA
⁸Hematology Department, University Hospital, Nantes, France
⁹Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL
¹⁰Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
¹¹Institute of Hematology and Transfusion Medicine, Warsaw, Poland
¹²University of California Irvine, Irvine, CA
¹³Florida Cancer Specialists, Sarah Cannon Research Institute, Sarasota, FL
¹⁴Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
¹⁵Fred Hutchinson Cancer Center, Seattle, WA
¹⁶University of Kansas Cancer Center, Kansas City, KS
¹⁷Linear Clinical Research and Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia
¹⁸Department of Haematology, St James's University Hospital, Leeds, United Kingdom
¹⁹University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
²⁰Università Vita-Salute San Raffaele and IRCCS San Raffaele Scientific Institute, Milan, Italy
²¹Department of Clinical Haematology, Oxford University Hospitals NHS Trust, Old Road, United Kingdom
²²Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
²³Winship Cancer Institute, Emory University, Atlanta, GA
²⁴Memorial Sloan Kettering Cancer Center, New York, NY
²⁵Loxo@Lilly, Indianapolis, IN
²⁶Eli Lilly and Company, Indianapolis, IN
²⁷Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy

Jorge J. Castillo, MD¹, Shayna R Sarosiek¹, Andrew R. Branagan, MD², Catherine A. Flynn, NP^1*, Megan Little^1*, Katherine Stockman^1*, Timothy P. White^1*, Alexandra N. Eurell^3*, Maria Luisa Guerrera, MD¹, Amanda Kofides^1*, Shirong Liu, MD, PhD^3*, Xia Liu, MD^1*, Kris Richardson, PhD^1*, Nickolas Tsakmaklis, BA^1*, Kirsten Meid, MPH^1*, Christopher J Patterson^1*, Zachary R Hunter, PhD¹ and Steven P. Treon, MD, PhD, FRCP¹

¹Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
²Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA
³Dana-Farber Cancer Institute, Boston, MA

Sameh Gaballa, MD¹, Ranjit Nair, MD², Ryan W Jacobs, MD³, Sumana Devata, MD⁴, Seok-Goo Cho^5*, Don A. Stevens, MD⁶, Dok Hyun Yoon, MD, PhD^7*, Nirav N. Shah, MD⁴, Denise Brennan^8*, Jason Law^8*, Robert Chen^9*, David Sermer^10*, Robin Lesley^11*, Ben Buelow^12*, Alessandra Forcina^9* and Jing-Zhou Hou¹³

¹H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
²The University of Texas MD Anderson Cancer Center, Houston, TX
³Atrium Health Levine Cancer Institute, Charlotte, NC
⁴Medical College of Wisconsin, Milwaukee, WI
⁵Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
⁶Norton Cancer Institute, Louisville, KY
⁷Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
⁸AstraZeneca, Waltham, MA
⁹AstraZeneca, Cambridge, United Kingdom
¹⁰AstraZeneca, New York, NY
¹¹AstraZeneca, South San Francisco, CA
¹²Ancora Biotech, Inc, Palo Alto, CA
¹³Lemieux Center for Blood Cancers, UPMC Hillman Cancer Center, Pittsburgh, PA

Jacqueline F. Wang, MD¹, Jihao Zhou, MD^2,3*, Steven R Hwang, MD², Catherine S Diefenbach, MD⁴, Jia Ruan, MD, PhD⁵, Peter Martin, MD⁵, Jonas Paludo, MD⁶, Javier L. Munoz⁷, Stephen M Ansell, MD, PhD², Thomas E. Witzig, MD⁶, Thomas M. Habermann, MD², James R. Cerhan, MD, PhD⁸, Grzegorz S. Nowakowski, MD² and Yucai Wang, MD, PhD²

¹Department of Medicine, NYU Langone Health, New York, NY
²Division of Hematology, Mayo Clinic, Rochester, MN
³Department of Hematology, Shenzhen People’s Hospital, Shenzhen, China
⁴Perlmutter Cancer Center at NYU Langone Health, New York, NY
⁵Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
⁶Mayo Clinic, Rochester, MN
⁷Department of Hematology, Mayo Clinic, Phoenix, AZ
⁸Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN

Danny Luan, MD, MPH¹, Neela Easwar, MD^2*, Zhengming Chen, PhD^3*, Brian K. Link, MD^4*, Yucai Wang, MD, PhD⁵, Matthew J. Maurer, DSc⁶, Brad S. Kahl, MD⁷, Laura Pinheiro^3*, John P. Leonard³ and Peter Martin, MD⁸

¹Newyork-Presbyterian Hospital/Weill Cornell Medical College, Astoria, NY
²Department of Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
³Weill Cornell Medicine, New York, NY
⁴Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
⁵Division of Hematology, Mayo Clinic, Rochester, MN
⁶Department of Health Sciences Research, Mayo Clinic, Rochester, MN
⁷Washington University School of Medicine in St. Louis, Saint Louis, MO
⁸Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY

Adam Suleman, MD¹, Zharmaine Ante^2*, Ning Liu, PhD^2*, Michael Crump, MD^3*, Kelvin KW Chan, MD, PhD^2,4*, Matthew C. Cheung, MD, MSc^2,5 and Anca Prica, MD, MSc^3*

¹Department of Medicine, University of Toronto, Toronto, ON, Canada
²Institute for Clinical Evaluative Sciences (ICES), Toronto, Canada
³Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, Canada
⁴Sunnybrook Health Sciences Centre, Toronto, Canada
⁵Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada

Jihao Zhou, MD^1,2*, Jacqueline F. Wang, MD³, Steven Ray Hwang, MD, BS², Jonas Paludo, MD⁴, Javier L. Munoz⁵, David James Inwards, MD^2*, Allison C. Rosenthal, DO⁶, William Breen, MD^7*, Scott Lester, MD^7*, Stephen M Ansell, MD, PhD², Thomas M. Habermann, MD², Thomas E. Witzig, MD⁴, Grzegorz S. Nowakowski, MD² and Yucai Wang, MD, PhD²

¹Department of Hematology, Shenzhen People’s Hospital, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Department of Medicine, NYU Langone Health, New York, NY
⁴Mayo Clinic, Rochester, MN
⁵Department of Hematology, Mayo Clinic, Phoenix, AZ
⁶Division of Hematology and Medical Oncology, Mayo Clinic, Phoenix, AZ
⁷Department of Radiation Oncology, Mayo Clinic, Rochester, MN

Francesco Autore^1*, Alessandra Tedeschi^2*, Giulia Benevolo, MD^3*, Veronica Mattiello, MD^4*, Eugenio Galli^5*, Nicolò Danesin, MD^6*, Rita Rizzi^7*, Jacopo Olivieri^8*, Emanuele Cencini^9*, Benedetta Puccini, MD^10*, Isacco Ferrarini, MD, PhD^11*, Dario Marino, MD, PhD^12*, Martina Bullo^13*, Bernardo Rossini^14*, Marina Motta, MD^15*, Idanna Innocenti, PhD^16*, Luca Stirparo, MD^17*, Diego Petrilli^17*, Raffaella Pasquale^18*, Pellegrino Musto, MD^7*, Greta Scapinello, MD^19*, Alessandro Noto, MD^20*, Veronica Peri, MD^21*, Giulia Zamprogna^22*, Stefan Hohaus^5*, Annamaria Frustaci, MD^23*, Francesco Piazza, MD^24*, Simone Ferrero, MD²⁵ and Luca Laurenti, MD^26*

¹Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
²ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
³University Hematology Division, Città della Salute e della Scienza Hospital, Torino, Italy, Torino, Italy
⁴Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
⁵Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy
⁶Azienda Ospedale Università di Padova, Padova, Italy
⁷Università di Bari "Aldo Moro," A.O.U. Consorziale Policlinico di Bari, Bari, Italy
⁸Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi", Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
⁹A.O.U. Senese and University of Siena, Siena, ITA
¹⁰A.O.U. Careggi, Firenze, Italy
¹¹A.O.U. Integrata di Verona – Borgo Roma,, Verona, Italy
¹²Oncologia 1, IRCCS Istituto Oncologico Veneto, Padova, Italy
¹³A.O. Ordine Mauriziano di Torino, Turin, AL, ITA
¹⁴IRCCS Istituto Tumori "Giovanni Paolo II” Bari, Bari, Italy
¹⁵Hematology, ASST Spedali Civili, Brescia, Italy
¹⁶Fondazione Universitaria Policlinico A Gemelli di Roma, Roma, Roma, Italy
¹⁷Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
¹⁸Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
¹⁹Department of Medicine, Hematology Unit, University of Padova, Padova, Italy, Padova, ITA
²⁰Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
²¹Division of Hematology, Department of Molecular Biotechnologies and Health Sciences, University of Torino, Torino, Italy
²²ASST Grande Ospedale Metropolitano Niguarda Hospital, Milano, ITA
²³Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
²⁴University of Padua, Padova, Italy
²⁵Ematologia Universitaria A.O.U. Città della Salute e della Scienza di Torino, Torino, Italy
²⁶Division of Hematology, Fondazione Universitaria Policlinico A Gemelli di Roma, Rome, Italy

Jahanzaib Khwaja¹, Nicole Japzon^2*, Maria Gabriel^3*, Charles Lilley^4*, Charalampia Kyriakou, MD, PhD^2*, Ali Rismani, FRCPath^2* and Shirley D'Sa, FRCP FRCPath MD(Res)^2*

¹University College London Hospital, London, United Kingdom
²University College London Hospitals NHS Foundation Trust, UCLH Centre for Waldenström macroglobulinaemia and Related Conditions, London, United Kingdom
³University College London, London, United Kingdom
⁴The UK Charity for Waldenström Macroglobulinaemia, WMUK, Cheshire, United Kingdom

Daniel A. Ermann, MD¹, Victoria A. Vardell, MD², Lindsey Fitzgerald, MD², Harsh Shah, DO², Allison M. Bock, MD², Deborah M. Stephens, DO² and Boyu Hu, MD²

¹Huntsman Cancer Institute, University of Utah, Omaha, NE
²Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Nicole McLaughlin¹, Ashlee Joseph^2*, Yucai Wang, MD, PhD³, Levi D. Pederson, MS^4*, Susan M. Geyer, PhD⁵, Thomas E. Witzig, MD⁴, Andrew D. Zelenetz, MD, PhD⁶, J. C. C Villasboas, MD^3*, Michael Scordo⁷, Paul A. Hamlin, MD⁸, N. Nora Bennani, MD⁴, Ariela Noy, MD⁸, Gita Thanarajasingam, MD³, Grzegorz S. Nowakowski, MD³, Luis Porrata, MD³, Carrie Thompson, MD, MS³, Ivana Micallef, MD^4*, Patrick B Johnston, MD, PhD^3*, Thomas M. Habermann, MD³, Stephen M Ansell, MD, PhD³, Anita Kumar, MD⁹ and Jonas Paludo, MD⁴

¹Hematology/Oncology, Mayo Clinic, Rochester, MN
²Memorial Sloan Kettering Cancer Center, New York
³Division of Hematology, Mayo Clinic, Rochester, MN
⁴Mayo Clinic, Rochester, MN
⁵Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN
⁶Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
⁹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ

Joshua W.D. Tobin, MD, PhD^1,2*, Rakin Chowdhury, MD^3*, Ross Salvaris, MBBS^4*, Alison Griffin^5*, Venkata Chikatamarla^6*, Amanda Goh, MBBS^6*, Tsz Hung Tong^7*, Callum Birks^8*, Sanjiv Jain^9*, Elizabeth Goodall, MBBS¹⁰, Shreerang Sirdesai^11*, Thomas Trevis^12*, Steinepreis Elizabeth^13*, Yiyang Chen^14*, Harrison Black^6*, Glenn Broadby^15*, Li Li, MD, PhD^16*, Naadir Gutta, FRACP, FRCPA^12*, Kirk Lachlan Morris, FRACP, FRCPA, MBBS¹⁷, Tara Cochrane, MBBS, FRCPA, FRACP¹⁸, Judith Trotman, MBChB, FRACP, FRCPA¹⁹, Dipti Talaulikar, PhD, FRACP, FRCPA, MBBS²⁰, Jake Shortt²¹, Georgina Hodges, FRACP, MBBS, FRCPA^22*, Chan Y. Cheah, MBBS, FRACP, FRCPA, DMSc²³, Allison A Barraclough, BSc, FRACP, FRCPA, MBBS²⁴, Kate Manos, MBBS^25*, Anna M. Johnston, MBBS, FRACP, FRCPA¹⁵, Jane Royle, MBBS^26*, Patrizia Mondello, MD, PhD, MSc²⁷, Stephen M Ansell, MD, PhD²⁷ and Greg Hapgood, M.D., Ph.D^28*

¹Mater Research Institute, Mater Health, Brisbane, QLD, Australia
²Department of Haematology, Princess Alexandra Hospital, Woolloongabba, QLD, Australia
³Princess Alexandra Hospital, Woolloongabba, QLD, Australia
⁴Sir Charles Gairdner Hospital, Nedlands, Australia
⁵QIMR berghofer, Brisbane, AUS
⁶Royal Brisbane & Women's Hospital, Brisbane, Australia
⁷Gold Coast University Hospital, Southport, Australia
⁸Concord Repatriation General Hospital, Concord, Australia
⁹Canberra Hospital, Garran, AUS
¹⁰Austin Health, Heidelberg, AUS
¹¹Barwon Health, University Hospital Geelong, Geelong, Australia
¹²Mater Hospital Brisbane, South Brisbane, Australia
¹³Fiona Stanley Hospital, Murdoch, Australia
¹⁴Flinders Medical Centre, Bedford Park, Australia
¹⁵Royal Hobart Hospital, Hobart, Australia
¹⁶Ochsner Clinic Foundation, New Orleans, LA
¹⁷Royal Brisbane and Women's Hospital, Herston, AUS
¹⁸Department of Haematology, Gold Coast University Hospital, Southport, Australia
¹⁹Concord Repatriation General Hospital, University of Sydney, Sydney, Australia
²⁰Australian National University, Canberra, ACT, Australia
²¹Monash University and Monash Health, Melbourne, VIC, Australia
²²Clinical Haematology, Barwon Health, Geelong, Australia
²³Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia
²⁴Haematology Department Fiona Stanley Hospital Murdoch, wa, Australia
²⁵Flinders Medical Centre, Bedford Park, AUS
²⁶Queensland Health, Townsville, AUS
²⁷Division of Hematology, Mayo Clinic, Rochester, MN
²⁸Princess Alexandra Hospital, Brisbane, AUS

Côme Bommier, MD, MSc^1,2*, Brian K. Link, MD^3*, Brianna Gysbers^4*, Matthew J. Maurer, DSc⁵, Melissa C. Larson, MS^1*, Arushi Khurana, MBBS⁴, Yucai Wang, MD, PhD⁶, Carrie Thompson, MD, MS⁶, Dai Chihara, MD, PhD⁷, Juan Pablo Alderuccio, MD⁸, Jean L. Koff, MD, MSc⁹, Izidore S. Lossos, MD¹⁰, Grzegorz S. Nowakowski, MD⁶, Andrew L. Feldman, MD¹¹, Thomas M. Habermann, MD⁶, Rebecca L. King, MD¹² and James R. Cerhan, MD, PhD¹³

¹Division of Epidemiology, Mayo Clinic, Rochester, MN
²Hematology/Oncology, Université Paris Cité, Hôpital Saint Louis, Inserm U1153, Paris, France
³University of Iowa, Iowa City, IA
⁴Mayo Clinic, Rochester, MN
⁵Department of Health Sciences Research, Mayo Clinic, Rochester, MN
⁶Division of Hematology, Mayo Clinic, Rochester, MN
⁷Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁸Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁹Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
¹⁰Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami School of Medicine, Miami, FL
¹¹Department of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester, MN
¹²Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
¹³Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN

Snegha Ananth, MBBS¹, Yi-Jiun Su, MD^2*, Mark P. Hamilton, MD³, Neha Agarwal, MS^4*, Wen-Kai Weng, MD, PhD¹, Saurabh Dahiya^1*, Sushma Bharadwaj, MD, MS^1,5, Jayasindhu Mallampet^1*, Melody Smith, MD, MS⁶, Katherine Ann Kong^7*, Abigail Twoy^7*, David B. Miklos, MD, PhD¹ and Matthew J. Frank, MD, PhD¹

¹Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Palo Alto, CA
²Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Palo Alto, CA
³Division of Hematology and Oncology, Stanford University, Palo Alto, CA
⁴Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
⁵Stanford, Palo Alto, CA
⁶Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University, Stanford, CA
⁷Division of Blood and Marrow Transplantation, Stanford University, Palo Alto, CA

Judith Trotman, MBChB, FRACP, FRCPA¹, Pier Luigi Zinzani, MD, PhD², Yuqin Song, MD³, Richard Delarue, MD⁴, Gisoo Barnes, PhD^5*, Pil Kim^5*, Elena Ivanova, PhD^5*, Boxiong Tang, MD⁵, Jiří Mayer, MD⁶, Ana C. De Oliveira, PhD^7*, Sarit Assouline, MD⁸ and Christopher R. Flowers, MD, MS⁹

¹Concord Repatriation General Hospital, University of Sydney, Sydney, Australia
²IRCCS Azienda Ospedaliero-Universitaria di Bologna  Istituto di Ematologia “Seràgnoli” and Dipartimento di Scienze Mediche e Chirurgiche,  Università di Bologna, Bologna, Italy
³Peking University Cancer Hospital and Institute, Beijing, China
⁴BeiGene Switzerland GmbH, Basel, Switzerland
⁵BeiGene (Shanghai) Co., Ltd. Shanghai, China and BeiGene USA, Inc., San Mateo, CA
⁶Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital, Brno, Czech Republic
⁷Clinical Hematology Department. Institut Català d’Oncologia, Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain
⁸Jewish General Hospital, McGill University, Montreal, QC, Canada
⁹Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX

Alba Cabirta Touzón, MD^1*, Adrian Mosquera Orgueira, MD, PhD^2*, Victor Navarro Garces^3*, Pau Abrisqueta, MD, PhD⁴, Rodrigo A Salcedo Pereda^2*, Carlos Aliste Santos^5*, Marta Canelo Vilaseca, MD^6*, Marina Gomez Rosa, MD^7*, Alberto Lopez Garcia, MD^8*, Tomas Garcia, MD, PhD^9*, Fatima De la Cruz Vicente, MD^10*, Juan-Manuel Sancho, MD, PhD^11*, Eduardo Rios Herranz, MD^7*, Raul Cordoba, MD, PhD⁸, Angel Serna, MD^12*, Gloria Iacoboni, MD^13*, Moraima Jiménez, MD^4*, Cecilia Carpio^14*, Cristina Garcia, MD^4*, Laura Gallur, MD^4*, Josep Castellvi, MD^15*, Francesc Bosch, MD, PhD⁴ and Ana Marin Niebla, MD, PhD^4*

¹Hematology Department, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain
²Hematology Department, University Hospital of Santiago de Compostela, Group of Computational Hematology and Genomics, IDIS, Santiago de Compostela, Spain
³Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
⁴Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
⁵Department of Pathology, University Hospital of Santiago de Compostela, Santiago de Compostela, Spain
⁶Hematology Department, University Hospital Germans Trias i Pujol, Badalona, Spain
⁷Hematology Department, University Hospital Ntra. Sra de Valme, Seville, Spain
⁸Hematology Department, University Hospital Fundación Jiménez Díaz, Madrid, Spain
⁹Hematology Department, University Hospital Arnau de Vilanova, Lleida, Spain
¹⁰Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla, University Hospital Virgen del Rocío, Seville, Spain
¹¹Hematology Department, ICO Badalona, Germans Trias i Pujol University Hospital. Universitat Autònoma de Barcelona. Josep Carreras Leukemia Research Institute, Barcelona, Spain
¹²Hematology Department,, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
¹³Hospital Universitari Vall d’Hebron-Universitat Autónoma de Barcelona, SEATTLE, WA
¹⁴University Hospital Vall d’Hebron, Barcelona, Spain
¹⁵Department of Pathology, Vall d'Hebron University Hospital, Barcelona, Spain

Rahul Lakhotia, MBBS¹, Christopher Melani, MD¹, Jagan R. Muppidi, MD, PhD^1*, Stefania Pittaluga, MD, PhD^2*, James D Phelan, PhD^1*, Colleen Ramsower, BS, MB^3*, Lisa M. Rimsza, MD⁴, Ryan S Robertorye^4*, George Wright^5*, Mark Meerson^6*, Ekaterina Postovalova, PhD^6*, Alexander Bagaev, PhD^6*, Nathan Fowler, MD^6*, Liza Lindenberg, MD^7*, Esther Mena, MD^7*, Ethan Bergvall^7*, Amynah Pradhan, NP^1*, Atekelt Tadese, PA^1*, Candis Morrison, NP, PhD^1*, Sarah Evans, RN^1*, Sumaya Berg, RN^1*, Seth M. Steinberg, PhD^8*, William Figg, PharmD^9*, Elaine S. Jaffe, MD¹⁰, Louis M. Staudt, MD, PhD¹, Wyndham H. Wilson, MD, PhD^1* and Mark Roschewski, MD¹

¹Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
²Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD
³Department of Research, Mayo Clinic, Scottsdale, AZ, Scottsdale, AZ
⁴Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, AZ
⁵Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁶BostonGene, Corp., Waltham, MA
⁷Molecular Imaging Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁸Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD
⁹Molecular Pharmacology Section, Genitourinary Malignancies Section, Center for Cancer Research, National Cancer Institute,, National Institutes of Health, Bethesda, MD
¹⁰CCR Lab of Pathology, National Cancer Institute, Bethesda, MD

Hang Su^1*, Tingyu Wang^2*, Xiuhua Sun^3*, Lihua Qiu^4*, Junning Cao⁵, Zhiming Li^6*, Yuqin Song, MD⁷, Li Zhang^8*, Dengju Li^9*, Huijing Wu, MD^10*, Wei Zhang^11*, Junmin Li^12*, Keshu Zhou, MD^13*, Hui Zhou^14*, Yu Yang^15*, Zhifeng Li^16*, Hong Cen^17*, Zhen Cai^18*, Zhihui Zhang, MD^19*, Weijun Fu^20*, Jie Jin IV^21*, Fei Li^22*, Weixin Wu^23*, Xuekui Gu^24*, Weiliang Zhu^25*, Lihong Liu^26*, Zengjun Li^27*, Shuhua Yi^28*, Hanying Bao^29*, Zusheng Xu^29* and Lugui Qiu²

¹307 Hospital Affiliated To the Academy of Military Medical Sciences, Beijing, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology& Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
³The Second Hospital of Dalian Medical University, Dalian, China
⁴Tianjin's Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Tianjin, China
⁵Department of Lymphoma, Fudan University Shanghai Cancer Center, Shanghai, China
⁶Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China
⁷Department of Lymphoma, Key laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, BEIJING, China
⁸West China Hospital, Sichuan University, Chengdu, China
⁹Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
¹⁰Hubei Cancer Hospital, Wuhan, China
¹¹Chinese Academy of Medical Sciences & Peking Union Medical College, Department of Hematology, Beijing, China
¹²Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
¹³Department of Hematology, Cancer Hospital Affiliated to Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
¹⁴Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China
¹⁵Fujian Provincial Cancer Hospital, The Affiliated Tumor Hospital of Fujian Medical University, Fuzhou, China
¹⁶Department of Hematology, The First Affiliated Hospital of Xiamen University and Institute of Hematology, School of Medicine, Xiamen University, Xiamen, Xiamen, China
¹⁷Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China
¹⁸Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
¹⁹Sichuan Cancer Hospital and Institute, Chengdu, China
²⁰Shanghai Fourth People’s Hospital, School of Medicine, Tongji University, Shanghai, China
²¹The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²²The First Affiliated Hospital of Nanchang University, Nanchang, China
²³Zhongshan Hospital, Xiamen University, Xiamen, China
²⁴Department of Hematology, , The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China
²⁵Zhujiang Hospital of Southern Medical University, Guangzhou, China
²⁶The Fourth Hospital of Hebei Medical University, Shijiazhuang, China
²⁷State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
²⁸Tianjin Institutes of Health Science, Tianjin, China
²⁹Shanghai Yingli Pharmaceutical Co., Ltd., Shanghai, China

Ana Marin Niebla, MD, PhD^1*, Mariana Bastos-Oreiro, MD^2*, Alba Cabirta Touzón, MD^3*, Marta Canelo Vilaseca, MD^4*, Juan-Manuel Sancho, MD, PhD^5*, Ana Jimenez Ubieto^6*, Adolfo Jesús Sáez Marín, MD^7*, Ana Garcia Noblejas, MD^8*, Pablo Prieto Martinez, MD^9*, Concepcion Nicolas, MD^10*, Carlos Grande Garcia, MD PhD^11*, Hugo Daniel Luzardo Henriquez, MD^12*, Jose Angel Hernandez Rivas, MD^13*, Ana Muntanola, MD PhD^14*, Rosalia Alonso Trillo, MD^15*, Irene Arnaiz, MD^15*, Eva Donato, MD PhD^16*, Paola Villafuerte Gutierrez, MD^17*, Daniel Garcia Belmonte, MD^18*, Alicia Roldan Perez, MD^19*, Sandra Suarez Ordonez, MD^20*, Víctor Navarro Garces^21*, Francesc Bosch, MD, PhD¹ and Pau Abrisqueta, MD, PhD¹

¹Hematology Department, Vall d’Hebron Institute of Oncology (VHIO), University Hospital Vall d’Hebron, Barcelona, Spain
²Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
³Hematology Department, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Barcelona, Spain
⁴Hematology Department, University Hospital Germans Trias i Pujol, Badalona, Spain
⁵Hematology Department, ICO Badalona, Germans Trias i Pujol University Hospital. Universitat Autònoma de Barcelona. Josep Carreras Leukemia Research Institute, Barcelona, Spain
⁶Hospital Universitario 12 de Octubre, MADRID, MADRID, Spain
⁷University of Complutense, Hospital 12 de Octubre, Madrid, Spain
⁸Hematology Department, Hospital Universitario La Princesa, Madrid, Spain
⁹Hematology Department, Hospital Universitario Puerta de Hierro, Madrid, Spain
¹⁰Hospital Central de Asturias, OVIEDO, Spain
¹¹Hematology Department, Clínica Universidad de Navarra, Madrid, ESP
¹²Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
¹³Hospital Universitario Infanta Leonor, Universidad Complutense, Madrid, Spain
¹⁴Hematology Department, Hospital Universitario Mutua de Terrassa, Terrassa, AL, ESP
¹⁵Hematology Department, Hospital Universitario de Getafe, Madrid, Spain
¹⁶Hematology Department, Hospita Universitario Doctor Peset, Valencia, ESP
¹⁷Hematology Department, Hospital Universitario Principe de Asturias, Madrid, ESP
¹⁸Hematology Department, Hospital Universitario La Zarzuela, Madrid, Spain
¹⁹Hematology Department, Hospital Universitario Infanta Sofía, Madrid, Spain
²⁰Hematology Department, Complejo Hospitalario de Vigo, Vigo, Spain
²¹Oncology Data Science (ODysSey), Vall d'Hebron Institute of Oncology (VHIO), Hospital Universitario Vall d’Hebron, Barcelona, Spain

Ewa Paszkiewicz-Kozik, MD^1*, Monika Palka, MD^2*, Malgorzata Debowska, Phd^3*, Marcin Szymanski, MD^4*, Agnieszka Konska^5*, Elzbieta Kalicinska, MD^6*, Agata Tyczynska^7*, Joanna Drozd-Sokolowska, MD, PhD^8*, Agnieszka Giza^9*, Ryszard Swoboda, MD^10*, Anna Paulina Dabrowska-Iwanicka, MD¹¹, Marta Morawska, MD^12*, Justyna Owczarek-Kaczmarek, MD^13*, Lukasz Bolkun, MD, PhD^14*, Anna Kopinska^15*, Ewa Wasik-Szczepanek, MD^16*, Dominika Maksylewicz, MD^17*, Anna Wisniewska, MD^18*, Lukasz Targonski, MD^4*, Edyta Subocz, MD^19*, Pawel Steckiewicz, MD^20*, Katarzyna Domanska-Czyz, MD^4*, Beata Ostrowska, MD^4*, Monika Swierkowska, MD^4*, Jacek Krzanowski, MD^13*, Agnieszka Druzd-Sitek^4*, Ewa Mroz-Zycinska, MD^4*, Joanna Romejko-Jarosinska, MD^4*, Iwona Hus, MD^21*, Monika Dlugosz-Danecka, MD^2*, Ewa Lech-Maranda, MD, PhD^22*, Tomasz Wrobel, MD, PhD^6*, Jan M. Zaucha^23* and Jan Walewski⁴

¹Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
²Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
³Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Warszawa, Poland
⁴Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland
⁵Institute of Hematology and Blood Transfusion, Warsaw, Poland
⁶Wroclaw Medical University, Wroclaw, Poland
⁷Medical University of Gdansk, Gdansk, Poland
⁸Medical University of Warsaw, Warszawa, Poland
⁹Jagiellonian University, Krakow, Poland
¹⁰Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland
¹¹Maria Sklodowska-Curie Memorial Cancer Center, Institute of Oncology, Warszawa, Poland
¹²St. John's Cancer Center, Lublin, Poland
¹³Brzozow Oncology Center, Brzozow, Poland
¹⁴Medical University of Bialystok, Bialystok, Poland
¹⁵Medical University of Silesia, Katowice, Poland
¹⁶Medical University in Lublin, Lublin, Poland
¹⁷Ludwik Rydygier Hospital, Krakow, Poland
¹⁸The Nicolas Copernicus State Hospital, Koszalin, Poland
¹⁹Warmian-Masurian Cancer Center of the Ministry of the Interior and Administration Hospital, Olsztyn, Poland
²⁰Holy Cross Cancer Center, Kielce, Poland
²¹The National Institute of Medicine of the Ministry of Interior and Administration, Warszawa, Poland
²²Institute of Hematology and Transfusion Medicine, Warsaw, Poland
²³Department of Hematology and Transplantology, Medical University of Gdańsk, Gdansk, Poland

Michele Merli^1*, Antonella Anastasia, MD^2*, Marina Deodato, MD^3*, Luca Nassi, MD^4*, Chiara Cavalloni, MD^5*, Silvia Franceschetti, MD^6*, Massimo Gentile, MD^7*, Annalisa Arcari, MD^8*, Roberto Sartori, MD^9*, Emanuele Cencini, MD^10*, Giacomo Loseto, MD^11*, Candida Vitale, MD, PhD^12*, Gioacchino Catania, MD^13*, Ombretta Annibali, MD, PhD^14*, Daniela Nasso, MD^15*, Federica Cocito, MD^16*, Isacco Ferrarini, MD, PhD^17*, Silvia Finotto, MD^18*, Alessandro Noto, MD^19*, Benedetta Bianchi, MD^1*, Andrea Ferrario, MD^1*, Marina Motta, MD^2*, Sara Rattotti, MD^5*, Annamaria Frustaci, MD^3*, Francesco Passamonti, MD^19,20* and Luca Arcaini^5,21*

¹Hematology, University Hospital "Ospedale di Circolo e Fondazione Macchi" - ASST Sette Laghi, Varese, Italy
²Hematology, ASST Spedali Civili, Brescia, Italy
³Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
⁴Hematology Department, Careggi Hospital and University of Florence, Novara, Italy
⁵Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁶Hematology Unit, Ospedale Civile di Legnano, ASST Ovest Milanese, Legnano, Italy
⁷Department of Onco-Hematology, Hematology Unit AO of Cosenza, Cosenza, Italy
⁸Division of Hematology, Guglielmo da Saliceto Hospital, Piacenza, Italy
⁹Ematologia Ospedale di Castelfranco Veneto, Castelfranco Veneto, Italy
¹⁰Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy
¹¹IRCCS Istituto Tumori “Giovanni Paolo II”, Hematology Unit, Bari, Italy
¹²Division of Hematology, A.O.U. Città della Salute e della Scienza di Torino and Department of Molecular Biotechnology and Health Sciences, University of Torino, Turin, Italy
¹³Hematology and Marrow Transplant,, A.O. SS Antonio e Biagio e Cesare Arrigo, Alessandria, Alessandria, ITA
¹⁴Hematology and Stem Cell Transplantation Unit, Fondazione Policlinico Universitario Campus Bio medico, Rome, Italy
¹⁵Hematology Unit, Center for Translational Medicine, Azienda USL Toscana Nord Ovest,, Livorno, ITA
¹⁶Hematology Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
¹⁷Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, ITA
¹⁸Oncologia1, Dipartimento di Oncologia, Istituto Oncologico Veneto IRCCS, Padova, Italy
¹⁹Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
²⁰Department of Oncology and Hematology, University of Milano Statale, Milan, Italy
²¹Department of Molecular Medicine, University of Pavia and Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Reith R Sarkar, MD^1*, Jasme Lee^2*, Zhigang Zhang^3*, Andrew D. Zelenetz, MD, PhD⁴, Gilles Salles, MD, PhD⁵, Joachim Yahalom, MD¹ and Brandon S. Imber, MD, MA¹

¹Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
²Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Epidemiology and Biostatistics, New York, NY
⁴Memorial Sloan Kettering Cancer Center, New York, NY
⁵Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York

Yuqin Song¹, Keshu Zhou, MD^2*, Dengju Li^3*, Jianda Hu⁴, Dehui Zou^5*, Sujun Gao^6*, Haiyan Yang⁷, Huilai Zhang, MD^8*, Jie Ji^9*, Wei Xu^10*, Ru Feng^11*, Jie Jin¹², Fangfang Lyu^13*, Cheng Fang^14*, Sheng Xu^14* and Jun Zhu, PhD¹⁵

¹Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute (Beijing Cancer Hospital), Beijing, China
²Department of Hematology, Cancer Hospital Affiliated to Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
³Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
⁴Department of Hematology, The Second Affiliated Hospital of Fujian Medical University, Fuzhou, China
⁵Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
⁶The First Hospital of Jilin University, Changchun, China
⁷Zhejiang Cancer Hospital, Hangzhou, China
⁸Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⁹Department of Hematology, West China Hospital of Sichuan University, Chengdu, China
¹⁰Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
¹¹Department of Hematology, Nanfang Hospital of Southern Medical University, Guangzhou, China
¹²The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China
¹³Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
¹⁴BeiGene (Shanghai) Co., Ltd., Shanghai, China
¹⁵Peking University Cancer Hospital, Beijing, China

Tycel Phillips, MD^1*, Laurie H. Sehn, MD, MPH², Anthony Wang, MPH, PhD^3*, Junhua Yu, PhD^4*, Elizabeth H. Marchlewicz, PhD^4*, Rajesh Kamalakar, MS^3*, Kavita Sail, PhD^4*, Donald Arnette, PhD^4*, Shibing Yang, PhD^5*, Alex Mutebi, PhD^5*, Fernando Rivas Navarro, MD^5* and Gilles Salles, MD, PhD⁶

¹City of Hope, Duarte, CA
²BC Cancer Centre for Lymphoid Cancer and The University of British Columbia, Vancouver, BC, Canada
³AbbVie, Inc., Chicago, IL
⁴AbbVie Inc., North Chicago, IL
⁵Genmab US, Inc., Plainsboro, NJ
⁶Memorial Sloan Kettering Cancer Center, New York, NY

Harsh Parmar, MBBS¹, Noa Biran, MD², Pooja Phull, MD^2*, David H. Vesole, MD, PhD^2,3 and David S. Siegel, MD, PhD^4,5

¹Multiple Myeloma Division, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
²Multiple Myeloma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
³Lombardi Comprehensive Cancer Center, Medstar Georgetown Medical Center, Washington, DC, DC
⁴Multiple Myeloma Division, Hackensack Univ. Med. Ctr., Hackensack, NJ
⁵Center for Discovery & Innovation, Hackensack Meridian Health, Nutley, NJ

Yingyue Liu^1*, Xiangxiang Zhou^2*, Linquan Zhan^1*, Mengyuan He^1*, Tiange Lu^1* and Xin Wang, MD, PhD^1,2

¹Department of Hematology, Shandong Provincial Hospital, Shandong University, Jinan, China
²Department of Hematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China

Giulio Cassanello, MD^1,2*, Alfredo Rivas-Delgado, MD, PhD³, Alejandro Luna De Abia, MD, PhD^1*, Magdalena Corona, MD^1*, Efrat Luttwak, MD⁴, Michelle Okwali, MPH^5*, Irem Isgor, MD^6*, Pallavi Galera, MBBS⁶, Alexander P. Boardman^7*, Philip Caron, MD⁴, Kevin A. David, MD^5*, Zachary D. Epstein-Peterson, MD⁴, Paola Ghione, MD, MSEpi⁸, Paul A. Hamlin, MD⁵, Jennifer Kimberly Lue, MD⁴, Steven M. Horwitz, MD⁸, Andrew M. Intlekofer, MD, DPhil⁴, William Johnson^8*, Anita Kumar, MD⁹, Alison Moskowitz, MD⁸, Ariela Noy, MD⁵, Colette Owens, MD⁴, Maria Lia Palomba, MD⁵, Robert Stuver, MD⁸, Pallawi Torka, MD¹⁰, Santosha A Vardhana, MD, PhD^5*, Andrew D. Zelenetz, MD, PhD⁴, Gilles Salles, MD, PhD⁵ and Lorenzo Falchi, MD⁵

¹Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²University of Milan, Milan, Italy
³Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Barcelona, Spain
⁴Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
⁶Department of Pathology and Laboratory Medicine, Hematopathology Service, Memorial Sloan Kettering Cancer Center, New York
⁷Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Memorial Sloan Kettering Cancer Center, New York, NY
⁹Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
¹⁰Lymphoma Service, Department of Medicine, MSKCC, New York, NY

Wei Li^1*, Ximei Zhang^1*, Fenghua Gao^1*, Yixin Yao, PhD², Xianhuo Wang^1* and Huilai Zhang, MD^1*

¹Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Preetesh Jain, MD, MBBS, PhD, DM¹, Hun Ju Lee, MD^2*, Jason Westin, MD³, Loretta J. Nastoupil, MD⁴, Luis Fayad, MD⁵, Ranjit Nair, MD⁶, Swami P. Iyer, MD¹, Rashmi Kanagal-Shamanna, MD⁷, Ahmed Fetooh, MD^8*, Holly A Hill, MS^9*, Chi Young Ok, MD¹⁰, Wendy Chen, BS, MPAS, MS^9*, Onyeka Oriabure, MSN, RN, NP^9*, Lei Feng, MS^11*, Guilin Tang, MD, PhD^10*, Francisco Vega, MD, PhD¹², Maria Badillo^8*, Christopher R. Flowers, MD, MS² and Michael L. Wang, MD¹³

¹Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Lymphoma and Myeloma, The University of Texas M D Anderson Cancer Center, Houston, TX
⁴MD Anderson Cancer Center, Houston, TX
⁵Lymphoma/Myeloma, M.D. Anderson Cancer Center, Houston, TX
⁶Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Pearland, TX
⁷Hematopathology, MD Anderson Cancer Center, Houston, TX
⁸Lymphoma/ Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
¹¹Biostatistics, UT MD Anderson Cancer Center, Houston, TX
¹²Department of Hematopathology, MD Anderson Cancer Center , Houston, TX
¹³Lymphoma/ Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX